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Abstract
We investigated the risk of, prognosis of and symptoms of multiple sclerosis (MS) among all Danish residents who owned
a mobile phone subscription before 1996. Using the Danish Multiple Sclerosis Registry and Civil Registration System, study
subjects were followed up for MS through 2004. Poisson models were used to calculate incidence rate ratios (IRR, age range:
18–64 years) and mortality rate ratios (MRR, age range: 18+) and to compare presenting symptoms among subscribers and
all non-subscribers. A total of 405 971 subscription holders accrued four million years of follow up, with men accounting for
86% of the observation time. Among subscription holding men, the IRR of MS was close to unity, overall as well as 13+ years
after first subscription (IRR 1.02, 95% CI: 0.48–2.16). Among women, the IRR was 3.43 (95% CI: 0.86–13.72) 13+ years after
first subscription, however, based on only two cases. Presenting symptoms of MS differed between subscribers and non-
subscribers (p=0.03), with slightly increased risk of diplopia in both genders (IRR: 1.38, 95% CI: 1.02–1.86), an increased risk
of fatigue among women (IRR: 3.02, 95% CI: 1.45–6.28), and of optic neuritis among men (IRR: 1.38, 95% CI: 1.03–1.86).
Overall the MRR was close to one (MRR: 0.91, 95%CI 0.70–1.19) among MS-patients with a subscription and although we
observed some increased MRR estimates among women, these were based on small numbers. In conclusion, we found little
evidence for a pronounced association between mobile phone use and risk of MS or mortality rate among MS patients.
Symptoms of MS differed between subscribers and nonsubscribers for symptoms previously suggested to be associated
with mobile phone use. This deserves further attention, as does the increased long-term risk of MS among female
subscribers, although small numbers and lack of consistency between genders prevent causal interpretation.
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Introduction
Usage of mobile phones has changed dramatically in the last
two decades, with steeply increasing number of users and
decreasing age at first use. The radiofrequency electromagnetic
fields (RF-EMF) emitted from mobile phones held to the head
penetrates up to six cm into the brain [1,2] and there remains
concern about potential adverse health effects. Epidemiological
studies have largely been on a potential risk of neoplasms,
particularly of the brain, and a working group at the International
Agency for Research on Cancer (IARC) has recently classified RF-
EMF as possibly carcinogenic [3]. For other diseases of the central
nervous system (CNS) and head, very few results are available.
One of the most frequent CNS diseases is multiple sclerosis (MS),
characterized by progressive demyelination of the axons of the
CNS causing a wide range of neurological symptoms. MS is
typically diagnosed in persons in their thirties. Only symptomatic
treatment is available, but survival is good [4], making MS
a leading cause of disability in younger adults in the developed
world [5]. In Denmark, the prevalence of MS in 2005 was
154.5 per 100 000 [6]. There are few established risk factors for
MS, but leakage across the blood brain barrier is prominent in the
pathophysiology of the disease. Therefore, it is of interest that
a Swedish research group has observed leakage of the blood brain
barrier in rats exposed to 900 MHz field from a GSM phone [7–
10]. Attempts to replicate these findings have, however, failed and
the overall evidence remains controversial [11–14]. Notwithstand-
ing this, the results may have caused concern in MS patients as to
whether mobile phones have an impact on their disease. A recent
nationwide Danish cohort study examined the association between
mobile phone use and risk of various CNS diseases based on
information on mobile phone subscription status prior to 1996
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e34453[15]. The study found no increased risk of MS overall or in mobile
phone subscribers with 10 or more years of subscription.
Information on MS was, however, obtained from the Danish
National Patient Register [16], which only provides few details on
each specific case and thus is prone to disease misclassification [17]
and underreporting, especially on date of diagnosis. The present
population-based epidemiologic study used the same cohort but
with information on MS from the Danish Multiple Sclerosis
Registry [18], which provides more precise case identification and
allows analysis of the influence of exposure status on the symptoms
and course of the disease. To our knowledge, this is the first study
examining the long term effects of mobile phone use on risk and
prognosis of MS.
Methods
Ethics Statement
The study was approved by the Danish ethical committee
system (KF 01–075/96), the Danish Data Protection Board (1996–
1200–121, 2009–41–3886), and the Danish Ministry of Justice
(Jnr. 1996–760–0219). In accordance with Danish law informed
consent was not obtained as the study was entirely register-based
and did not involve biological samples from, or contact with study
participants.
Study Population
We conducted this study within the population of Denmark
during the period 1987–2004. All Danish citizens are assigned
a unique personal identification number at birth by the Danish
Central Population Registry (CPR), which keeps complete
information about the date of birth, gender, vital status, migration
and current and former addresses of all Danes [19]. This
identification number is applied universally in all contacts within
the health care systems in Denmark allowing individuals to be
tracked over time in and across all Danish administrative and
health registers.
Ascertainment of MS Cases
MS cases were identified from the Danish Multiple Sclerosis
Registry [18,20] established in 1956. The register contains
information on more than 90% of all MS patients in Denmark
since 1949 and is considered to have a validity of 94%. For each
patient the medical records have been evaluated and the year of
the first symptom has been assessed. Furthermore, the first
symptom(s) for each patient in the register are recorded, and
multiple simultaneous symptoms are allowed. For the present
paper, only definite and probable diagnoses according to the Poser
criteria [21] were included.
Exposure Assessment
Records of all (723 421) mobile phone subscriptions in Denmark
during the period 1982 (when this service was established) until the
end of 1995 were obtained from the Danish network operatoros.
Details of the cleaning process of these data has been reported
previously [15,22–24]: Briefly, 200 507 corporate subscriptions
were deleted and 102 828 records were deleted for other reasons
including errors in matching variables and duplicate records
(persons with multiple subscriptions) leaving a cohort of 420 086
private mobile phone subscription holders. Since handheld mobile
phones first became available in Denmark in 1987, all subscription
periods were left truncated to 1 January 1987, further deleting four
persons from the dataset. The unexposed population was obtained
by subtracting the number of MS-cases and exposed persons from
the Danish population count by age and gender for each year of
the study. Only persons, who turned 18 years before January 1
st
1996, i.e., end of exposure period, were included in the analysis.
Risk of MS Among Subscription Holders
In analyses of risk of MS and presenting symptoms among
mobile phone subscription holders, symptom free subjects entered
the study population on 1 January 1987 or age 18 years, whichever
occurred latest. Follow-up ended at date of MS diagnosis, age 65
years, death, emigration from Denmark or 31 December 2004,
whichever came first. Exposed person time was further categorized
based on duration of follow-up since date of first subscription (,1,
1–3, 4–6, 7–9, 10–12, 13+ years). In a subanalysis, we used July 1
st
in the year of the first recorded symptom(s) as endpoint. Due to the
retrospective nature of debut data follow-up was, for this analysis,
terminated on 31 December 2000 allowing four years until 2004 to
identify patients with first symptoms in 2000 or earlier. In these
analyses, we excluded 13 573 subscription holders who obtained
their subscription after age 65 years, 30 with MS symptoms before
age 18 years, 366 with symptoms before 1987 and 142 diagnosed
with MS before getting a subscription, yielding a population of 405
971 mobile phone subscription holders.
Risk of Death Among MS-patients
In analyses of risk of death among MS patients using mobile
phone, MS patients diagnosed between age 18 and 65 years in
1980 or later entered the study population at date of diagnosis or 1
January 1987, whichever came latest. Follow-up ended at date of
death, emigration from Denmark or on 31 December 2004,
whichever came first. A total of 7420 MS-patients met the
inclusion criteria, of whom 717 were subscription holders. For
these patients, exposed person-years were cumulated from date of
diagnosis or date of subscribing, whichever came last, and
subdivided into five categories (,1, 1–3, 4–6, 7–9, 10+ years).
Likelihood of Subscribing for a Mobile Phone Among MS
Patients
To evaluate a potentially reverse association, we analysed MS as
an explanatory factor for obtaining a subscription in the 5 050 MS
patients with a first symptom between age 18 and 65 years in the
period 1980 to 1995. Entry and exit criteria were as for the main
analysis, except that subjects were censored at the date of
subscription acquisition, or on 31 December 1995, and not at
the time of the MS-diagnosis. Time after first MS-symptom was
subdivided according to diagnostic status (1st symptom, diagnosis),
and years since first symptom and since diagnosis (,1, 1–3, 4–6,
7–9, 10+ years).
Statistical Analysis
Log-linear Poisson regression analysis was used to compute
incidence and mortality rate ratios (IRRs or MRRs) for MS
diagnosis, MS debut and risk of death in MS patients among
mobile phone subscription holders compared to non-subscribers.
The analyses were adjusted for gender, age (in incidence analyses:
18–29, 30–39, 40–49 and 50–65 years; in mortality analyses:18–
29, 30–39, 40–49, 50–59, 60–69, 70–79 and 80+ years) and
individual calendar year (1987 to 2004 by increments of 1 year).
Subjects were allowed to change between categories of covariates
and exposure variables over time. When analysing risk of death,
years since diagnosis was included as a linear covariate.
The presenting symptoms of MS among subscribers and
nonsubscribers were compared by analysing MS diagnoses with
different initial symptoms as competing risks in a Poisson model as
Mobile Phones and Multiple Sclerosis
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each symptom.
For date variables with missing day values, the 15th of the
respective month was used and when the month was missing, July
1st was used. As only the year of first symptom was available, the
date of first symptom was set to July 1st of the given year or the
actual date of diagnosis, whichever came first. The statistical
analyses were performed in SAS 9.1.
Results
The gender and age profile of new subscription holders changed
dramatically over the course of the exposure (mobile phone
subscription) period (Fig. 1). In 1990, 0.1% of all women and 1.9%
of all men aged 18–65 years owned a subscription in their own
name, with the highest proportion in middle-aged men. In 1995,
3.6% of all women had a subscription with penetration decreasing
gradually above age 45 years. In men the penetration was above
20% from age 19 to 47 years, decreasing rapidly in the older ages.
Risk of MS Among Subscription Holders
The 405 971 subscription holders accrued 4 063 040 years of
follow up (mean 10.0 years; maximum 18.0 years). The overall
risks of MS in subscription holding women and men were 1.02
(95% CI: 0.83–1.24) and 1.11 (95% CI: 0.98–1.26), respectively
(Table 1). Stratification of subscription holders by years since first
subscription showed a slight overall increase in IRR of MS among
male subscribers of 10 to 20% in the period from 1–9 years after
first subscription, however, there was no elevation in risk before or
after that interval. Among women, elevated IRRs were seen in the
first year after subscription (1.61; (95% CI: 0.93–2.79, n=13) and
beyond 10 years of subscription (2.08; 95%CI: 1.08–4.01, n=9),
whereas the risk estimates were close to one in the intervening
period. Further restricting the follow-up period to 13+ years
showed an even higher estimate (IRR: 3.43, 95%CI: 0.86–13.72),
however based on only two cases. In analysis of both genders,
IRRs ranged from 1.04 to 1.09, except in the stratum of 13+ years
of subscribing where there was a 26% increased risk of MS (95%
CI 0.65–2.43).
Analysing until year of first symptom yielded similar results
when comparing ever versus never subscribing. However, among
men we observed a 33% increased risk of having the first symptom
within one year of obtaining a subscription. In subsequent years
there was little deviation from unity, except in the strata of 10+
years of usage where the risk was reduced by half but based on
only two cases (IRR: 0.50, 95%CI 0.13–2.02). Among women,
there was a 30% decreased risk in the first year after subscribing
and the only estimate above one was for 10+ years of subscribing
where there was a more than six fold increased risk, however based
on only two cases.
Presenting Symptoms
Presenting symptoms of MS differed significantly between
subscribers and non-subscribers (Table 2) overall and among
women, but not among men (respective p-values: 0.03, 0.02 and
0.46). When examining the individual symptoms, there was
a slightly increased risk of diplopia (double vision) in both genders;
with an IRR of 1.38 (95% CI: 1.02-1.86, n=54) in combined
Figure 1. Mobile phone subscription penetration in the Danish population by age in 1990 and 1995.
doi:10.1371/journal.pone.0034453.g001
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increased risk of fatigue (IRR: 3.02, 95% CI: 1.45–6.28, n=8),
and among men there was increased risk of optic neuritis (IRR:
1.38, 95% CI: 1.03–1.86, n=58).
Risk of Death Among MS-patients
The 717 subscription holding MS-patients accrued 4 934 years
of exposed follow-up from 1987 onwards (mean: 6.9 years;
maximum 18.0 years). The overall MRRs of death were 1.27 (95%
CI: 0.77–2.09) and 0.79 (95% CI: 0.58–1.09) among female and
Table 1. Adjusted rate ratios for Multiple Sclerosis among private subscribers to mobile phones in Denmark, 1987–1995, followed
up through 2004.
Women Men Total
Person
years MS IRR 95% CI
Person
years MS IRR 95% CI
Person
years MS IRR 95% CI
Until diagnosis
Non subscribers 27 517 890 3 531 Reference 25 309 803 1 517 Reference 52 827 693 5 048 Reference
Subscription holders 572 177 102 1.02 (0.83–1.24) 3.490.862 304 1.11 (0.98–1.26) 4 063 040 406 1.06 (0.96–1.18)
Years of subscription
,1 60 044 13 1.61 (0.93–2.79) 344 413 18 0.91 (0.57–1.46) 404 457 31 1.09 (0.76–1.56)
1–3 176 918 26 1.00 (0.68–1.48) 1 012 944 70 1.12 (0.87–1.44) 1 189 862 96 1.05 (0.85–1.29)
4–6 171 243 28 0.84 (0.58–1.22) 975 610 100 1.21 (0.98–1.50) 1 146 853 128 1.08 (0.90–1.29)
7–9 139 559 26 0.91 (0.61–1.34) 840 374 91 1.11 (0.89–1.39) 979 932 117 1.04 (0.86–1.26)
10–12 20 847 7 1.87 (0.89–3.94) 234 295 18 0.88 (0.55–1.41) 255 142 25 1.04 (0.70–1.54)
13+ 3 567 2 3.43 (0.86–13.72) 83 227 7 1.02 (0.48–2.16) 86 794 9 1.26 (0.65–2.43)
10+ 24 414 9 2.08 (1.08–4.01) 317 522 25 0.92 (0.61–1.37) 341 936 34 1.09 (0.77–1.53)
Until 1st symptom
Non subscribers 21 929 622 3 336 Reference 20 599 730 1 485 Reference 42.529.353 4 821 Reference
Subscription holders 351 972 57 0.94 (0.72–1.23) 2 261 285 195 1.10 (0.94–1.28) 2 613 258 252 1.05 (0.92–1.19)
Years of subscription
,1 60 012 7 0.70 (0.33–1.48) 344 332 33 1.33 (0.94–1.90) 404 344 40 1.11 (0.81–1.52)
1–3 176 836 30 0.98 (0.69–1.41) 1 012 638 84 1.06 (0.84–1.33) 1 189 474 114 1.02 (0.84–1.24)
4–6 104 217 17 0.93 (0.58–1.51) 705 980 65 1.09 (0.84–1.41) 810 197 82 1.06 (0.84–1.32)
7–9 8 703 1 0.73 (0.10–5.16) 138 245 11 1.06 (0.59–1.93) 146 948 12 1.05 (0.60–1.86)
10+ 2 204 2 6.75 (1.69–27.05) 60 091 2 0.50 (0.13–2.02) 62 295 4 0.99 (0.37–2.65)
doi:10.1371/journal.pone.0034453.t001
Table 2. Adjusted rate ratios for Multiple Sclerosis with different first symptoms among private subscribers to mobile phones in
Denmark, 1987–1995, followed up through 2004.
Women Men Total
Unexposed
cases
Exposed
cases IRR 95% CI
Unexposed
cases
Exposed
cases IRR 95% CI
Unexposed
cases
Exposed
cases IRR 95% CI
Person years 27 517 890 572 177 25 309 803 3 490 862 52 827 693 4 063 040
Cerebellar
symptoms
326 4 0.40 (0.15–1.08) 138 21 0.81 (0.51–1.30) 464 25 0.67 (0.44–1.01)
Diplopia 300 14 1.59 (0.92–2.72) 157 40 1.32 (0.92–1.89) 457 54 1.38 (1.02–1.86)
Optic neuritis 694 23 1.08 (0.71–1.64) 217 58 1.38 (1.03–1.86) 911 81 1.24 (0.97–1.57)
Pyramidal
dysfunction
837 17 0.71 (0.44–1.15) 452 80 1.00 (0.78–1.27) 1 289 97 0.90 (0.73–1.12)
Sensory symptoms 1 836 50 0.92 (0.69–1.22) 653 130 1.02 (0.84–1.24) 2 489 180 0.98 (0.84–1.15)
Sphincter control 116 1 0.27 (0.04–1.97) 63 15 1.20 (0.68–2.14) 179 16 0.95 (0.56–1.61)
Vertigo 226 8 0.95 (0.47–1.92) 61 12 0.79 (0.43–1.47) 287 20 0.85 (0.53–1.35)
Fatigue 74 8 3.02 (1.45–6.28) 40 11 1.09 (0.56–2.12) 114 19 1.61 (0.96–2.69)
Other/Unstated
symptoms
355 8 1.28 (0.63–2.59) 145 23 1.30 (0.82–2.06) 500 31 1.30 (0.89–1.89)
doi:10.1371/journal.pone.0034453.t002
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compared to patients without subscription. In combined analysis
of the two genders, the IRR was 0.91 (95% CI: 0.70–1.19). Among
men, the risk of death was reduced by half or more in the first four
years of exposed follow-up time, especially in the interval from 1–3
years after which the death risk estimates approached unity.
Among women, the death estimates varied more, but did not
deviate significantly from unity, except among female MS patients
with 7–9 years of mobile phone usage after diagnosis (MRR, 2.44;
95% CI: 1.20–4.98; n=8). The combined analysis of the two
genders revealed a 40% decreased MRR in the first four years and
a 41% increase seven to nine years after subscribing.
Likelihood of Subscribing for a Mobile Phone Among MS
Patients
The 5 050 MS patients accrued 29 993 person years from 1987
to 1995 (mean, 5.9 years; maximum 9.0 years). Among women,
there was no increased likelihood of obtaining a subscription after
first symptoms or in the first year after being diagnosed with MS
(Table 4). Beyond that there was a tendency for an increased
likelihood of obtaining a subscription (IRRs ranging from 1.18–
1.44). Among men, there was no overall association with first
symptoms or diagnosis of MS. However, in the first four years after
getting the symptom, the IRRs were 25% elevated and beyond
that they were around 20% decreased. Once diagnosed with MS,
there was no apparent increased likelihood of acquiring a mobile
phone subscription, except in the period 1–3 years after diagnosis
(IRR: 1.22; 95% CI: 0.97–1.54). In combined analysis of the two
genders, there was no indication of an increased likelihood of
acquiring a subscription after first symptoms or diagnosis. Except
for a 26% increased tendency for subscription 1–3 years after
diagnosis (95% CI: 1.04–1.53), there was no apparent trends
between first symptoms or MS diagnosis and mobile phone
subscription in the combined analysis of the two genders.
Discussion
In our population-based cohort study of mobile phone
subscription holders, we found no overall increased risk of MS
among subscription holders, irrespective of whether analyzed until
clinical MS diagnosis or until first recorded symptom. Neither did
we find any overall increased risk of death among subscription
holding MS-patients. Among subgroups of women, we did observe
some risk increases of MS, MS-symptoms and death after long-
term subscription, however, the numbers were small in these
analyses and may have been chance findings. Among men, we
found a tendency towards increased risks of MS-symptoms, in the
first year after mobile phone subscription, and of MS in the period
1–9 years after first subscription. Among male MS patients, the
risk of death appeared to be decreased in the first years of mobile
phone exposure, approaching unity after 4 years. The first
symptoms of MS were different among mobile phone users
compared to non-subscribers, with subscription holders having
more frequent fatigue among women, increased optic neuritis
among men, and diplopia in both sexes.
Risk of MS-diagnosis in Subscription Holders
Our observation of an increased risk of MS among men 1–9
years after first subscription could be due to reverse causation,
particularly since men were somewhat more likely to obtain
a subscription in the years immediately after being recorded with
their first symptoms. However, as a large proportion of MS cases
were diagnosed within the first few years after their first symptom,
we would have expected to also see a risk increase in the first year
after first subscription. We did observe slightly increased risk of
first symptoms of MS within the first year after first subscription.
This could be a triggering/promoting effect, but such effects would
likely also affect women, contrary to our findings, and it therefore
seems more likely a chance finding or detection bias related to use
of the mobile phone. In addition, there is also the possibility of
reverse causation, since only the year of first recorded symptom
and not the actual date of first symptom experienced was available
for most subjects, therefore the temporal resolution does not allow
exact sequencing of events within the year of first symptom. This
interpretation is supported by the fact that we observed both an
increased chance of obtaining a subscription in the year of the first
symptom and an increased risk of having a first symptom of future
MS within the first year after first subscription. Among female
mobile phone users, we observed a doubling in risk of MS 10 or
more years after first subscription, however, this finding was based
on very few cases, and the limited statistical precision in
combination with lack of dose response and disagreement with
the results in men suggests chance as a more likely explanation.
The fact that the risk was also present when analysing until first
Table 3. Risk of death among Multiple Sclerosis patients with private subscriptions to mobile phones in Denmark. 1987–1995,
followed up through 2004.
Women Men Total
Person
years Deaths MRR 95% CI
Person
years Deaths MRR 95% CI
Person
years Deaths MRR 95% CI
Non
subscribers 39 575 400 Reference 18 333 306 Reference 57 908 706 Reference
Subscription
holders 1 339 16 1.27 (0.77–2.09) 3 595 45 0.79 (0.58–1.09) 4 934 61 0.91 (0.70–1.19)
Years of subscription after MS-diagnosis
,1 190 2 1.35 (0.33–5.45) 509 2 0.40 (0.10–1.64) 700 4 0.59 (0.22–1.59)
1–3 487 4 1.06 (0.39–2.85) 1 305 7 0.47 (0.22–1.00) 1 792 11 0.58 (0.32–1.06)
4–6 382 2 0.57 (0.14–2.00) 934 14 0.91 (0.53–1.57) 1 317 16 0.90 (0.54–1.48)
7–9 246 8 2.44 (1.20–4.98) 645 16 1.06 (0.63–1.78) 891 24 1.41 (0.93–2.15)
10+ 33 0 – 202 6 0 93 (0.41–2.12) 235 6 0.95 (0.42–2.15)
doi:10.1371/journal.pone.0034453.t003
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follow-up period was restricted to 13+ years may, however, merit
further attention. It should also be kept in mind that the first
female users who were the most likely long term exposed subjects
were a select subgroup of presumably affluent women, and
therefore confounding may also have influenced the results.
Debut Symptoms
Fatigue was more frequent among female mobile phone
subscribers, but not among men. Although tiredness/fatigue is
among the more common complaints in mobile users [25,26], and
there is some evidence that RF-EMF from mobile phones
influences EEG [27], the lack of consistency in results between
genders and the small numbers do not allow firm conclusions
based on our data. We observed an increased risk of optic neuritis
among male subscribers and diplopia (double vision) was elevated
in both genders. A recent laboratory study found no effect on
visually evoked potentials in GSM exposed men [28], but effects of
short term exposure in a laboratory may differ from effects due to
long term exposure. Several small questionnaire-based cross-
sectional studies have reported an increased occurrence of blurring
of vision (among the symptoms of both optic neuritis and diplopia)
among mobile phone users, although the impact of participation
and reporting biases should be considered in the interpretation of
these studies [29–32]. Also, self-reported ‘‘blurring of vision’’ is
a very vague endpoint, compared to the MS-registry which
contains, thoroughly validated, records of symptoms persisting for
longer periods. Although the overall composition of symptoms in
our study did not differ significantly by exposure status for men,
the uniformly increased risk in both genders for diplopia indicates
that these observations merit further study. If future studies
corroborate that the symptom picture differs, it should be
considered that the visual nerve may be in the exposure field,
but also that the battery in mobile phones heats up when the
phone is in operation and that heating may elicit symptoms in MS-
patients [33,34].
Risk of Death in MS-patients
We did not observe an increased risk of death in MS cases
following mobile subscription, rather, among men, there was
a tendency for a decreased risk of death in the first years after
obtaining a subscription. These estimates were, however, based on
small numbers, and the risk decrease among men is likely
attributable to chance. It is, however, conceivable that there is
a healthy subscriber bias at the time of mobile phone acquisition as
its use requires the physical and cognitive capabilities to operate
the mobile phone as well as spending enough time away from
a landline phone to justify the extra expense. The numbers of
deaths among female MS patients with mobile phone subscription
were too small to allow any conclusions.
Likelihood of Subscribing for a Mobile Phone in MS
Patients
It is a general epidemiological concern that early symptoms of
the outcome of interest may have a reverse effect on the likelihood
of exposure and thereby make it difficult to discern cause and
effect. For instance, migraine-like symptoms are more common in
MS-patients [35], and the Danish Migraine Association has been
advising migraine patients to obtain a mobile phone to facilitate
access to help in case of an attack. For women in our study, the
likelihood of obtaining a subscription was only increased more
than one year after being diagnosed with MS, indicating that for
women the disease may indeed influence the likelihood of getting
a subscription but only during a period of little impact on the risk
analyses. Among men, there was no effect of being diagnosed with
MS on the likelihood of obtaining a subscription; there was,
however, some indication of an increased likelihood of getting
a subscription in the first four years after being diagnosed with the
Table 4. Likelihood of getting subscription after diagnosis or first symptoms of Multiple Sclerosis among private subscribers to
mobile phones in Denmark, 1987–1995.
Women Men Total
Person
years Subscrpt IRR 95% CI
Person
years Subscrpt IRR 95% CI
Person
years Subscrpt IRR 95% CI
Non- MS 14 376 975 60 019 Reference 14 188 947 338 243 Reference 28 565 922 398 262 Reference
Diagnostic stage
Symptoms 8 604 41 1.00 (0.73–1.35) 3 857 97 1.04 (0.85–1.27) 12 461 138 1.04 (0.88–1.22)
Diagnosis 11 172 86 1.22 (0.99–1.51) 6 360 193 1.00 (0.87–1.15) 17 532 279 1.07 (0.95–1.21)
Years since 1st MS-symptom (Censor at diagnosis)
,1 1 581 7 1.00 (0.48–2.10) 742 21 1.24 (0.81–1.90) 2 323 28 1.17 (0.81–1.69)
1–3 3 168 8 0.61 (0.31–1.23) 1 512 40 1.25 (0.92–1.71) 4 680 48 1.07 (0.80–1.42)
4–6 2 052 12 1.31 (0.74–2.30) 874 17 0.85 (0.53–1.36) 2 926 29 1.00 (0.69–1.43)
7–9 1 190 6 0.96 (0.43–2.14) 501 11 0.78 (0.43–1.40) 1 692 17 0.84 (0.52–1.35)
10+ 612 8 1.41 (0.70–2.81) 228 8 0.82 (0.41–1.64) 840 16 1.07 (0.65–1.74)
Years since MS-diagnosis
,1 1 629 6 0.67 (0.30–1.50) 865 24 1.02 (0.69–1.52) 2 494 30 0.93 (0.65–1.33)
1–3 4 068 31 1.31 (0.92–1.87) 2 252 72 1.22 (0.97–1.54) 6 320 103 1.26 (1.04–1.53)
4–6 2 849 23 1.44 (0.96–2.17) 1 735 48 0.96 (0.72–1.28) 4 584 71 1.08 (0.86–1.37)
7–9 1 735 14 1.18 (0.70–2.00) 1 010 32 0.94 (0.67–1.33) 2 745 46 1.02 (0.76–1.36)
10+ 891 12 1.20 (0.68–2.11) 498 17 0.64 (0.40–1.04) 1 389 29 0.81 (0.56–1.17)
doi:10.1371/journal.pone.0034453.t004
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causation bias is a potential problem in our analyses, especially
since the effect may be present even before the year of the first
recorded symptoms, if prodromal symptoms exist. Data on this
issue were, however, sparse and the effect estimates did not reach
significance. It is therefore not possible to substantiate if the
observed associations are chance findings or true associations
applicable to other studies.
Strengths and Limitations
Our study was a nationwide cohort study based on objective
and prospectively registered exposure data with validated and
carefully evaluated outcome data from a nationwide high quality
register [18]. The applied register approach practically eliminates
loss to follow-up and provides accurate and virtually complete
nationwide ascertainment of MS-cases. The validated diagnoses in
the MS-register allowed more reliable estimates than in the
previous publication of the same exposure cohort where MS was
assessed from hospital admissions [15]. In addition, the details on
type and date of early symptoms of MS from the MS-registry also
allowed us to explore if mobile usage had any impact on the
symptom pattern or course of the disease, although we only had
the year of first symptom as recorded retrospectively from medical
journals and not the actual date of the first symptoms experienced.
Furthermore, the exposure assessment was improved in our study
by left-truncating exposure data to 1987, thereby reducing
misclassification of exposure due to car phones that were available
in Denmark since 1982, but in terms of exposure to the head are
several orders of magnitude lower than handheld phones.
A limitation of the study was the lack of exposure details and
potential exposure misclassification [36]. Subscription holders not
using their mobile phone may erroneously be classified as exposed
or vice versa. However, according to the annual report of the
Danish national IT and Telecom Agency, the average annual
outgoing traffic per subscription was around 1400 min/sub-
scription until 1992 when it started to decrease, stabilizing at
around 900 min/subscription from 1995 to 2002 [37]. This
change presumably reflects that the very early users had sufficient
need of the mobile phone to justify the expensive subscription.
When examining risk at 10+ or even 13+ years of follow-up, where
the exposure contrast was the largest, we found no increased risks
of MS, MS-symptoms or death among men. Among women,
however, we did see indications of increased risks for the various
outcomes among long-term subscribers, although the numbers
were too small to allow reliable interpretation. For several
outcomes, we observed somewhat different associations among
men and women. Although we cannot rule out gender differences,
differences in residual confounding seem more likely given the fact
that the uptake of mobile phones was so different, in time and
potentially in reasons, combined with the established gender
difference in MS incidence [38].
Conclusions
We found little evidence for an association between mobile
phone use and risk of MS or of death in MS patients in this
nationwide study of mobile phone subscribers in Denmark. We
did, however, observe an increased risk of both MS symptoms and
diagnosis among long-term female subscribers, although this was
based on small numbers. The presenting symptoms of MS differed
between subscribers and nonsubscribers with elevated risks for
symptoms previously suggested to be associated with mobile phone
use (visual disturbances and fatigue) observed among the mobile
phone users. These observations merit further attention in more
detailed studies, such as the ongoing prospective COSMOS study
[39], which will allow more detailed exposure assessment,
collecting information on potential confounders and detailed
chronological information to identify potential reverse causation
bias.
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